KBIO LABS Inc. (KOSDAQ:038530)
South Korea
· Delayed Price · Currency is KRW 1,550.00
-35.00 (-2.21%)
At close: Apr 13, 2026
KBIO LABS Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 87,312 | 76,514 | 27,325 | 31,129 | 8,722 | Upgrade
|
| Other Revenue | - | - | - | -0 | - | Upgrade
|
| Revenue | 87,312 | 76,514 | 27,325 | 31,129 | 8,722 | Upgrade
|
| Revenue Growth (YoY) | 14.11% | 180.02% | -12.22% | 256.89% | 52.80% | Upgrade
|
| Cost of Revenue | 74,795 | 64,854 | 23,730 | 27,457 | 6,823 | Upgrade
|
| Gross Profit | 12,517 | 11,660 | 3,595 | 3,671 | 1,899 | Upgrade
|
| Selling, General & Admin | 8,564 | 8,257 | 3,695 | 3,001 | 5,986 | Upgrade
|
| Research & Development | 1,321 | 1,132 | - | - | - | Upgrade
|
| Amortization of Goodwill & Intangibles | 19.94 | 255.52 | 333.9 | 333.9 | 58.35 | Upgrade
|
| Other Operating Expenses | 224.22 | 273.27 | 65.02 | 80.58 | 150.43 | Upgrade
|
| Operating Expenses | 11,761 | 12,770 | 4,212 | 3,218 | 6,986 | Upgrade
|
| Operating Income | 755.63 | -1,110 | -616.78 | 453.41 | -5,087 | Upgrade
|
| Interest Expense | -53.95 | -78.02 | -60.82 | -1,207 | -1,781 | Upgrade
|
| Interest & Investment Income | 1,647 | 1,843 | 838.47 | 995.31 | 929.97 | Upgrade
|
| Currency Exchange Gain (Loss) | -133.92 | 995.81 | 0.75 | -2.26 | -0.32 | Upgrade
|
| Other Non Operating Income (Expenses) | 5.77 | 198.19 | 16,366 | -1,457 | 58.91 | Upgrade
|
| EBT Excluding Unusual Items | 2,220 | 1,849 | 16,527 | -1,217 | -5,880 | Upgrade
|
| Gain (Loss) on Sale of Investments | -7,094 | -7,820 | -28,301 | -5,757 | -10,705 | Upgrade
|
| Gain (Loss) on Sale of Assets | 4.48 | 0.79 | -26.74 | 14.28 | - | Upgrade
|
| Asset Writedown | -12.01 | -3,890 | - | -54.46 | - | Upgrade
|
| Other Unusual Items | - | - | -17.45 | - | - | Upgrade
|
| Pretax Income | -4,881 | -9,861 | -11,817 | -7,015 | -16,585 | Upgrade
|
| Income Tax Expense | 162.07 | 132.3 | - | - | - | Upgrade
|
| Earnings From Continuing Operations | -5,043 | -9,993 | -11,817 | -7,015 | -16,585 | Upgrade
|
| Earnings From Discontinued Operations | - | - | -857.05 | -650.4 | -2,881 | Upgrade
|
| Net Income to Company | -5,043 | -9,993 | -12,674 | -7,665 | -19,466 | Upgrade
|
| Minority Interest in Earnings | 1,844 | 3,202 | - | - | - | Upgrade
|
| Net Income | -3,200 | -6,791 | -12,674 | -7,665 | -19,466 | Upgrade
|
| Net Income to Common | -3,200 | -6,791 | -12,674 | -7,665 | -19,466 | Upgrade
|
| Shares Outstanding (Basic) | 23 | 23 | 20 | 18 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 23 | 23 | 20 | 18 | 15 | Upgrade
|
| Shares Change (YoY) | -0.73% | 12.65% | 12.29% | 17.81% | 737.44% | Upgrade
|
| EPS (Basic) | -140.00 | -295.00 | -620.16 | -421.16 | -1260.03 | Upgrade
|
| EPS (Diluted) | -140.00 | -295.00 | -621.94 | -421.16 | -1261.50 | Upgrade
|
| Free Cash Flow | 8,160 | -190.34 | -1,471 | 3,768 | -1,213 | Upgrade
|
| Free Cash Flow Per Share | 357.06 | -8.27 | -71.98 | 207.05 | -78.51 | Upgrade
|
| Gross Margin | 14.34% | 15.24% | 13.16% | 11.79% | 21.77% | Upgrade
|
| Operating Margin | 0.86% | -1.45% | -2.26% | 1.46% | -58.33% | Upgrade
|
| Profit Margin | -3.67% | -8.88% | -46.38% | -24.62% | -223.18% | Upgrade
|
| Free Cash Flow Margin | 9.35% | -0.25% | -5.38% | 12.11% | -13.91% | Upgrade
|
| EBITDA | 1,693 | -25.92 | -125.74 | 1,045 | -4,413 | Upgrade
|
| EBITDA Margin | 1.94% | -0.03% | -0.46% | 3.36% | -50.60% | Upgrade
|
| D&A For EBITDA | 937.55 | 1,084 | 491.03 | 591.58 | 674 | Upgrade
|
| EBIT | 755.63 | -1,110 | -616.78 | 453.41 | -5,087 | Upgrade
|
| EBIT Margin | 0.86% | -1.45% | -2.26% | 1.46% | -58.33% | Upgrade
|
| Advertising Expenses | 51.26 | 45.94 | 4 | 0.93 | 1,087 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.